diabetes mellitus, type ii

Showing 1 - 25 of 57

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type II, Overweight or Obesity Trial (Shake 1 then Shake 2, Shake 2 then Shake 1)

Not yet recruiting
  • Diabetes Mellitus, Type II
  • Overweight or Obesity
  • Shake 1 then Shake 2
  • Shake 2 then Shake 1
  • (no location specified)
Jul 13, 2023

Diabetes, Type II Trial in Singapore (16 weeks digital intervention)

Active, not recruiting
  • Diabetes Mellitus, Type II
  • 16 weeks digital intervention
  • Singapore, Singapore
    EVYD Technology Limited
Dec 4, 2022

Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Technology Intensified)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • +4 more
  • Technology Intensified
  • Charleston, South Carolina
    Medical University of South Carolina
Apr 4, 2022

Diabetes, Type II Trial in Charleston (Fenofibrate)

Completed
  • Diabetes Mellitus, Type II
  • Charleston, South Carolina
    Medical University of South Carolina
Jan 11, 2022

Diabetes, Type II Trial in United States (Metformin, Rosiglitazone, Lifestyle Program)

Completed
  • Diabetes Mellitus, Type II
  • Los Angeles, California
  • +15 more
Jul 28, 2021

Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Diabetes Knowledge/Information,

Completed
  • Diabetes Mellitus, Type 2
  • +4 more
  • Diabetes Knowledge/Information
  • +3 more
  • Charleston, South Carolina
    Medical University of South Carolina
Jun 16, 2021

Diabetes, Type II, Periodontitis Trial in Buffalo (drug, procedure, device)

Completed
  • Diabetes Mellitus, Type II
  • Periodontitis
  • Chlorhexidine gluconate oral rinse
  • +2 more
  • Buffalo, New York
    University at Buffalo
Apr 14, 2021

Diabetic Patients: Identification of Treatment Non-Responders

Completed
  • Diabetes Mellitus, Type II
  • Intensified Treatment of risk factors
  • Graz, Austria
    Department of Internal Medicine, Medical University of Graz
Feb 25, 2021

Diabetes, Type II, Obesity Trial in Cambridge (MEDI0382, Placebo)

Completed
  • Diabetes Mellitus, Type II
  • Obesity
  • Cambridge, United Kingdom
    Research Site
Feb 11, 2021

Diabetes, Type II Trial in Asheville (Liraglutide, Insulin)

Completed
  • Diabetes Mellitus, Type II
  • Asheville, North Carolina
    Mountain Diabetes and Endocrine Center
Feb 23, 2021

Diabetes, Type II Trial (Retagliptin, Henagliflozein, metformin XR)

Not yet recruiting
  • Diabetes Mellitus, Type II
  • Retagliptin, Henagliflozein, metformin XR
  • (no location specified)
Dec 9, 2020

Insulin Sensitivity During Hyperbaric Oxygen Compared to

Completed
  • Diabetes Mellitus, Type II
  • Insulin Resistance
  • HBO
  • Hyperbaric air
  • Adelaide, South Australia, Australia
    Hyperbaric Medicine Unit, Royal Adelaide Hospital
Nov 2, 2020

Diabetes, Type II Trial in Durham (Type 2 Diabetes Self-Management)

Completed
  • Diabetes Mellitus, Type II
  • Type 2 Diabetes Self-Management
  • Durham, North Carolina
    Duke University School of Nursing
Jul 1, 2020

Diabetes, Type 2, Diabetes, Type II, Diabetes, Adult-Onset Trial in Stanford (Victoza (liraglutide) with dietician monitoring,

Completed
  • Diabetes Mellitus, Type 2
  • +3 more
  • Victoza (liraglutide) with dietician monitoring
  • Placebo with dietician monitoring
  • Stanford, California
    Freidenrich Center for Translational Research (FCTR)
Jun 6, 2020

Diabetes, Type II, Hypoglycemia, Cognitive Change Trial in Copenhagen (Hypoglycaemic clamp, Euglycaemic clamp)

Completed
  • Diabetes Mellitus, Type II
  • +2 more
  • Hypoglycaemic clamp
  • Euglycaemic clamp
  • Copenhagen, Denmark
    Department of Research in Endocrinology, Bispebjerg University H
Jan 14, 2020

Diabetes, Type II Trial in Barcelona (Walk@WorkApp-Diab)

Unknown status
  • Diabetes Mellitus, Type II
  • Walk@WorkApp-Diab
  • Barcelona, Spain
    IDIAP Jordi Gol
Sep 16, 2019

Diabetes, Type II Trial in Jeonju (D308, CKD-501)

Completed
  • Diabetes Mellitus, Type II
  • D308, CKD-501
  • Jeonju, Korea, Republic of
    Chonbuk National University Hospital
Nov 15, 2018

Diabetes, Type II Trial in Hanover (Empagliflozin, Glimepiride, Empagliflozin )

Terminated
  • Diabetes Mellitus, Type II
  • Hanover, Lower Saxony, Germany
    Hannover Medical School, University Eye Hospital and CRC Core Fa
Sep 26, 2018

Diabetes, Type II Trial in Saint Louis (Metformin, Rosiglitazone, Lovaza)

Completed
  • Diabetes Mellitus, Type II
  • Saint Louis, Missouri
    Washington University in St. Louis
Aug 24, 2018

Diabetes, Type II Trial in Valparaiso (GOLO RELEASE)

Completed
  • Diabetes Mellitus, Type II
  • GOLO RELEASE
  • Valparaiso, Indiana
    Buynak Clinical Research
Mar 23, 2018

Glucose Control on Response to Aspirin in Type 2 Diabetic

Completed
  • Diabetes Mellitus, Type II
    • Jerusalem, Israel
      Hadassah Medical Organization
    Aug 9, 2017

    Diabetes, Type II Trial in Jeonju-si (Duvie Tab. 0.5mg, Glucophage XR Tab. 500mg, CKD-395 0.25/500mg)

    Completed
    • Diabetes Mellitus, Type II
    • Duvie Tab. 0.5mg, Glucophage XR Tab. 500mg
    • CKD-395 0.25/500mg
    • Jeonju-si, Jeollabuk-do, Korea, Republic of
      Chonbuk National University Hospital
    Aug 8, 2017

    Diabetes, Type II Trial in Cairo (zinc supplement plus vitamin A and E, vitamin A and E)

    Completed
    • Diabetes Mellitus, Type II
    • zinc supplement plus vitamin A and E
    • vitamin A and E
    • Cairo, Egypt
      theoutpatient clinics, department of internal medicine, Cairo Un
    Aug 6, 2017

    Diabetes, Type II, Insulin Resistance Trial in Bethesda, Richmond (Exercise cardiopulmonary metabolic testing, Skeletal muscle

    Completed
    • Diabetes Mellitus, Type II
    • Insulin Resistance
    • Exercise cardiopulmonary metabolic testing
    • +2 more
    • Bethesda, Maryland
    • +1 more
    Jun 30, 2017

    Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Tablets Intervention)

    Completed
    • Diabetes Mellitus, Type 2
    • +4 more
    • Tablets Intervention
    • Charleston, South Carolina
      Medical University of South Carolina
    May 5, 2017